Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-17

Clinical Trial Update: Study and Analysis of Micafungin for Non-albican Candidemia: Efficacy, Risk Factor and Clinical Manifestation

View source ↗

Summary

A completed clinical trial evaluating micafungin for non-albicans candidemia, assessing efficacy, risk factors, and clinical manifestations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mycamine (Micafungin)

Snippet

Sponsor: Taipei Medical University WanFang Hospital | Conditions: Non-albicans Candidemia | Status: COMPLETED